William Alexander Chutkow, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thioredoxins | 8 | 2014 | 202 | 1.310 |
Why?
|
| Carrier Proteins | 10 | 2020 | 4948 | 0.620 |
Why?
|
| Potassium Channels | 4 | 2002 | 538 | 0.560 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2002 | 144 | 0.540 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2022 | 2145 | 0.400 |
Why?
|
| Heart Failure | 8 | 2024 | 11857 | 0.360 |
Why?
|
| Adipogenesis | 1 | 2011 | 370 | 0.310 |
Why?
|
| Gene Deletion | 4 | 2014 | 2674 | 0.300 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2001 | 568 | 0.280 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 2056 | 0.250 |
Why?
|
| Insulin | 4 | 2011 | 6606 | 0.230 |
Why?
|
| Receptors, Drug | 2 | 2001 | 157 | 0.230 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 82 | 0.200 |
Why?
|
| Coronary Vasospasm | 1 | 2002 | 81 | 0.200 |
Why?
|
| Blood Glucose | 5 | 2019 | 6429 | 0.190 |
Why?
|
| Pregnancy Complications | 3 | 2010 | 2969 | 0.190 |
Why?
|
| Stroke Volume | 4 | 2024 | 5620 | 0.190 |
Why?
|
| Proteomics | 3 | 2024 | 3901 | 0.190 |
Why?
|
| Arrestin | 2 | 2011 | 30 | 0.180 |
Why?
|
| Hepatocytes | 1 | 2007 | 1247 | 0.180 |
Why?
|
| Arrestins | 2 | 2011 | 73 | 0.180 |
Why?
|
| Adiposity | 1 | 2010 | 1888 | 0.170 |
Why?
|
| Anhydrides | 1 | 2019 | 29 | 0.160 |
Why?
|
| Sorbitol | 1 | 2019 | 60 | 0.160 |
Why?
|
| Muscle Proteins | 2 | 2020 | 1165 | 0.160 |
Why?
|
| Tetrazoles | 1 | 2024 | 922 | 0.150 |
Why?
|
| Adenosine Triphosphate | 3 | 2011 | 2003 | 0.150 |
Why?
|
| Drug Combinations | 1 | 2024 | 2079 | 0.150 |
Why?
|
| Mixed Function Oxygenases | 1 | 1999 | 265 | 0.150 |
Why?
|
| Glucose Clamp Technique | 3 | 2010 | 263 | 0.150 |
Why?
|
| Pheochromocytoma | 2 | 2009 | 328 | 0.140 |
Why?
|
| Electrocardiography | 2 | 2010 | 6410 | 0.140 |
Why?
|
| Homeostasis | 2 | 2007 | 3351 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 843 | 0.140 |
Why?
|
| Exons | 2 | 2001 | 2392 | 0.140 |
Why?
|
| Muscle, Skeletal | 3 | 2007 | 4984 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1996 | 431 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2002 | 1494 | 0.120 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2009 | 736 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1094 | 0.110 |
Why?
|
| Mice, Knockout | 7 | 2011 | 14480 | 0.110 |
Why?
|
| Liver | 2 | 2007 | 7575 | 0.110 |
Why?
|
| Metanephrine | 2 | 2009 | 25 | 0.110 |
Why?
|
| 3T3-L1 Cells | 2 | 2011 | 208 | 0.110 |
Why?
|
| Cardiomegaly | 2 | 2023 | 591 | 0.100 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2014 | 210 | 0.100 |
Why?
|
| Catecholamines | 2 | 2010 | 390 | 0.100 |
Why?
|
| Mice | 15 | 2023 | 82045 | 0.100 |
Why?
|
| Myocardium | 2 | 2012 | 4788 | 0.090 |
Why?
|
| Ventricular Function, Left | 2 | 2024 | 3941 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2011 | 243 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 236 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2594 | 0.090 |
Why?
|
| Pulmonary Edema | 2 | 2009 | 409 | 0.090 |
Why?
|
| Glucose | 1 | 2001 | 4355 | 0.080 |
Why?
|
| Protein Stability | 1 | 2011 | 584 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 930 | 0.080 |
Why?
|
| 3T3 Cells | 1 | 2010 | 1086 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 484 | 0.080 |
Why?
|
| Body Weight | 1 | 2019 | 4630 | 0.080 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2007 | 72 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2007 | 96 | 0.070 |
Why?
|
| Obesity | 3 | 2019 | 13065 | 0.070 |
Why?
|
| Animals | 16 | 2023 | 169418 | 0.070 |
Why?
|
| Thermogenesis | 1 | 2011 | 494 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 401 | 0.070 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 303 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 11930 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2023 | 3145 | 0.060 |
Why?
|
| Adipose Tissue, Brown | 1 | 2011 | 776 | 0.060 |
Why?
|
| Glutathione | 1 | 2007 | 587 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12774 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2007 | 2232 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2011 | 2751 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2012 | 1361 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2007 | 842 | 0.060 |
Why?
|
| Disulfides | 1 | 2006 | 467 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2901 | 0.050 |
Why?
|
| DNA Primers | 2 | 1999 | 2826 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1744 | 0.050 |
Why?
|
| Aptamers, Nucleotide | 1 | 2024 | 166 | 0.050 |
Why?
|
| Angina Pectoris, Variant | 1 | 2002 | 53 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2007 | 773 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 6091 | 0.050 |
Why?
|
| Hypertension | 1 | 2002 | 8611 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2010 | 2003 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4294 | 0.050 |
Why?
|
| Fasting | 1 | 2007 | 1608 | 0.050 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2001 | 241 | 0.050 |
Why?
|
| Humans | 20 | 2024 | 768451 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 5162 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 307 | 0.050 |
Why?
|
| Deoxyglucose | 1 | 2001 | 333 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 12242 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6551 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 437 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 13452 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 1026 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 692 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2007 | 1389 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 478 | 0.040 |
Why?
|
| Introns | 1 | 2001 | 970 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 381 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17647 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2001 | 1181 | 0.040 |
Why?
|
| Fetal Death | 2 | 2009 | 438 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3440 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2024 | 1066 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2009 | 583 | 0.030 |
Why?
|
| Biological Transport | 1 | 2001 | 2089 | 0.030 |
Why?
|
| Base Sequence | 2 | 1999 | 12428 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2010 | 3974 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1136 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 1998 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 1152 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 1036 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1435 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2002 | 1568 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 1064 | 0.030 |
Why?
|
| Pregnancy | 3 | 2010 | 30179 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 2465 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 1223 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6242 | 0.030 |
Why?
|
| Female | 10 | 2024 | 396943 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2103 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1906 | 0.030 |
Why?
|
| Prognosis | 2 | 2024 | 30028 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2011 | 140 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 239 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2007 | 8538 | 0.020 |
Why?
|
| Dyspnea | 2 | 2009 | 1352 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1972 | 0.020 |
Why?
|
| Iceland | 1 | 2011 | 184 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 11515 | 0.020 |
Why?
|
| Weight Gain | 1 | 2001 | 2357 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4175 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 808 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9558 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1996 | 1349 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 387 | 0.020 |
Why?
|
| Pre-Eclampsia | 2 | 2009 | 1257 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 347 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6527 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2910 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2011 | 371 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4622 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1129 | 0.020 |
Why?
|
| Male | 7 | 2024 | 364781 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 838 | 0.020 |
Why?
|
| Qb-SNARE Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Tachycardia | 1 | 2009 | 599 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 190 | 0.020 |
Why?
|
| Cell Line | 2 | 2014 | 15609 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12813 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 986 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 399 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5909 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 3612 | 0.020 |
Why?
|
| Risk Factors | 2 | 2023 | 74915 | 0.010 |
Why?
|
| Plasmids | 1 | 2009 | 2269 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2011 | 23638 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 7605 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1532 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2012 | 2131 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 223418 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 579 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1164 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18388 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3790 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1282 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2630 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22293 | 0.010 |
Why?
|
| Headache | 1 | 2009 | 1260 | 0.010 |
Why?
|
| Cysteine | 1 | 2006 | 895 | 0.010 |
Why?
|
| Adipocytes | 1 | 2007 | 1199 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 171520 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 1280 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4180 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6995 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5767 | 0.010 |
Why?
|
| Sex Factors | 1 | 2011 | 10647 | 0.010 |
Why?
|
| Mutation | 2 | 2014 | 30243 | 0.010 |
Why?
|
| Echocardiography | 1 | 2009 | 5043 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59680 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5803 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 223542 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 13026 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 3111 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9376 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2011 | 13030 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60045 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19041 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 10090 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9623 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 22365 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2011 | 41797 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 16029 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18048 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36840 | 0.000 |
Why?
|